Centaurus Financial Inc. increased its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 15.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,421 shares of the company’s stock after acquiring an additional 464 shares during the period. Centaurus Financial Inc.’s holdings in Colgate-Palmolive were worth $355,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. Gordian Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at $602,000. Carrera Capital Advisors increased its position in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after acquiring an additional 7,353 shares in the last quarter. Vontobel Holding Ltd. raised its stake in shares of Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after acquiring an additional 550,750 shares during the last quarter. PGGM Investments lifted its position in shares of Colgate-Palmolive by 171.8% during the second quarter. PGGM Investments now owns 157,608 shares of the company’s stock worth $15,294,000 after purchasing an additional 99,624 shares in the last quarter. Finally, QRG Capital Management Inc. grew its stake in shares of Colgate-Palmolive by 11.2% during the second quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock valued at $5,558,000 after purchasing an additional 5,751 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.37% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on CL
Colgate-Palmolive Stock Performance
CL opened at $96.59 on Wednesday. The company has a market capitalization of $78.91 billion, a price-to-earnings ratio of 27.68, a P/E/G ratio of 3.39 and a beta of 0.42. The business’s 50-day moving average price is $97.74 and its two-hundred day moving average price is $98.59. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- The Role Economic Reports Play in a Successful Investment Strategy
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What Are Dividend Champions? How to Invest in the Champions
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Where to Find Earnings Call Transcripts
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.